5 Stocks With Bad Operating Margin Growth — PGNX SYUT CTEL HKTV IMMU

by Portfolio Grader | March 4, 2013 7:00 pm

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader[1].

Progenics Pharmaceuticals (NASDAQ:PGNX[2]) develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. PGNX also gets F’s in Earnings Momentum, Equity, Cash Flow, and Sales Growth. For more information, get Portfolio Grader’s complete analysis of PGNX stock[3].

Synutra International (NASDAQ:SYUT[4]) manufactures infant formula and other nutritional products. SYUT also gets F’s in Earnings Growth, Earnings Momentum, Analyst Earnings Revisions, Equity, Cash Flow, and Sales Growth. For more information, get Portfolio Grader’s complete analysis of SYUT stock[5].

City Telecom (H.K.) Ltd. (NASDAQ:CTEL[6]) provides fixed telecommunications networks and international telecommunications services for residential and corporate customers. CTEL also gets F’s in Earnings Growth and Sales Growth. For more information, get Portfolio Grader’s complete analysis of CTEL stock[7].

HKTV gets F’s in Earnings Growth and Sales Growth as well. For more information, get Portfolio Grader’s complete analysis of HKTV stock[8].

Immunomedics (NASDAQ:IMMU[9]) develops, manufactures, and sells diagnostic imaging and therapeutic products. IMMU gets F’s in Earnings Growth, Equity, Cash Flow, and Sales Growth as well. Since January 1, IMMU has fallen 23.3%. This is worse than the Nasdaq, which has seen a 1.8% increase over the same period. For more information, get Portfolio Grader’s complete analysis of IMMU stock[10].

Louis Navellier’s proprietary Portfolio Grader[1] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[11].

Endnotes:

  1. Portfolio Grader: https://navelliergrowth.investorplace.com/portfolio-grader/
  2. PGNX: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=PGNX
  3. For more information, get Portfolio Grader’s complete analysis of PGNX stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=PGNX
  4. SYUT: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=SYUT
  5. For more information, get Portfolio Grader’s complete analysis of SYUT stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=SYUT
  6. CTEL: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=CTEL
  7. For more information, get Portfolio Grader’s complete analysis of CTEL stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=CTEL
  8. For more information, get Portfolio Grader’s complete analysis of HKTV stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=HKTV
  9. IMMU: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=IMMU
  10. For more information, get Portfolio Grader’s complete analysis of IMMU stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=IMMU
  11. here: https://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: https://investorplace.com/2013/03/5-stocks-with-bad-operating-margin-growth-pgnx-syut-ctel-hktv-immu-pgnx-syut-ctel-hktv-immu-2/